ReadiSorb’s research follows a familiar path in product development. We began with cell culture studies, advanced to animal models, and ultimately into clinical trials.
Our early laboratory studies demonstrated that ReadiSorb Liposomal Glutathione (RLG) effectively delivered glutathione into cells and supported important antioxidant and immune-related functions. Animal studies later showed promising effects on oxidative stress, cardiovascular health, and immune response.
Building on these findings, multiple published clinical studies have since evaluated RLG in individuals with low glutathione levels, demonstrating its ability to safely increase glutathione levels and support healthy immune function. This research progression reflects ReadiSorb’s long-standing commitment to scientific validation and evidence-based development.
Recommended Reading
A 2015 Clincal Study documenting Absorption and Immune Support